GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0001906 | Cell killing |
| Process | GO:0002227 | Innate immune response in mucosa |
| Process | GO:0002237 | Response to molecule of bacterial origin |
| Process | GO:0002251 | Organ or tissue specific immune response |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002385 | Mucosal immune response |
| Process | GO:0006950 | Response to stress |
| Process | GO:0006952 | Defense response |
| Process | GO:0006955 | Immune response |
| Process | GO:0006959 | Humoral immune response |
| Process | GO:0009605 | Response to external stimulus |
| Process | GO:0009607 | Response to biotic stimulus |
| Process | GO:0009617 | Response to bacterium |
| Process | GO:0009620 | Response to fungus |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0019730 | Antimicrobial humoral response |
| Process | GO:0019731 | Antibacterial humoral response |
| Process | GO:0031640 | Killing of cells of another organism |
| Process | GO:0032496 | Response to lipopolysaccharide |
| Process | GO:0033993 | Response to lipid |
| Process | GO:0035821 | Modulation of process of another organism |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042742 | Defense response to bacterium |
| Process | GO:0043207 | Response to external biotic stimulus |
| Process | GO:0044419 | Biological process involved in interspecies interaction between organisms |
| Process | GO:0045087 | Innate immune response |
| Process | GO:0050829 | Defense response to Gram-negative bacterium |
| Process | GO:0050830 | Defense response to Gram-positive bacterium |
| Process | GO:0050832 | Defense response to fungus |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051673 | Membrane disruption in another organism |
| Process | GO:0051707 | Response to other organism |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0061844 | Antimicrobial humoral immune response mediated by antimicrobial peptide |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071216 | Cellular response to biotic stimulus |
| Process | GO:0071219 | Cellular response to molecule of bacterial origin |
| Process | GO:0071222 | Cellular response to lipopolysaccharide |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071396 | Cellular response to lipid |
| Process | GO:0098542 | Defense response to other organism |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901701 | Cellular response to oxygen-containing compound |
| Component | GO:0005576 | Extracellular region |
| Component | GO:0005615 | Extracellular space |
| Component | GO:0110165 | Cellular anatomical entity |
Pathway annotation
| Category | Term ID | Term description |
|---|---|---|
| RCTM | RNO-1461973 | Defensins |
| RCTM | RNO-1462054 | Alpha-defensins |
| RCTM | RNO-168249 | Innate Immune System |
| RCTM | RNO-168256 | Immune System |
| RCTM | RNO-6798695 | Neutrophil degranulation |
| RCTM | RNO-6803157 | Antimicrobial peptides |
| KEGG | rno04621 | NOD-like receptor signaling pathway |
| KEGG | rno05150 | Staphylococcus aureus infection |
| KEGG | rno05202 | Transcriptional misregulation in cancer |
Expression profile of Defa11 in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 3.1709907 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 2.7523997 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 3.2094963 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 3.2715702 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 3.0181725 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 2.88342 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 3.5736196 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 2.8976543 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 3.4497826 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 3.6713765 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 2.538504 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 2.8770492 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 2.58084 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 2.7801125 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 2.3262157 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 3.8188136 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 2.3701637 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 4.8632097 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 4.0637374 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 2.5710938 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 2.9836507 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 2.6908123 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 2.4377708 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 3.5536363 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 2.614992024 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 2.188369554 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 2.484990798 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 2.738758105 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 2.97291375 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 3.260753664 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 0.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 1.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 0.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 4.404768 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 4.552219 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 4.533358 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 4.98142 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 4.667825 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 4.538689 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 0.0 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 0.0 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 0.0 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 0.0 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 0.0 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 4.79619 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 4.57127 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 4.77696 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 4.8478 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 4.19882 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 4.67545 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 4.83089 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 4.34652 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 3.94487 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 3.64251 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 4.29796 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 3.96192 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 4.22138 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 3.58859 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 4.13143 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 3.79235 |
